AI and Annotated Medical Images – OpenPath, PLIP, and “Medical Twitter”

By Michael Awood

September 1, 2023

The lack of available annotated medical images has historically hindered healthcare innovation. However, a solution is emerging as healthcare professionals start to share anonymised images and insights on public platforms – which includes the social media site previously known as Twitter (X). This has led to the creation of OpenPath, a comprehensive dataset of over 200,000 pathology images coupled with natural language descriptions, marking it as the largest public dataset of its kind.

Researchers have used OpenPath to develop Pathology Language–Image Pre-training (PLIP), a multimodal AI trained on this dataset. PLIP has demonstrated impressive results in zero-shot learning and transfer learning for classifying new pathology images across various tasks. Additionally, PLIP enables users to locate similar cases using either image or natural language search, encouraging knowledge sharing.

The researchers collected over 240,000 public pathology images using popular pathology-related hashtags and expanded the collection with data from other online sources. After thorough data quality checks, they assembled over 200,000 pathology image-text pairs named OpenPath, which they used to develop the versatile PLIP.

PLIP outperformed previous models in tasks such as zero-shot learning, linear probing, and text-to-image and image-to-image retrieval. Unlike other digital pathology machine learning methods, PLIP can adapt to new datasets and provide zero-shot predictions based on any text input, making it a flexible tool for potential new disease subtypes.

The study did note some limitations, including irrelevant data in the image-text pairs and challenges in accounting for varying magnification levels and staining styles. However, researchers are optimistic that PLIP can adjust to images with diverse magnification levels and staining protocols. They expect that OpenPath and PLIP will significantly contribute to advancing AI in pathology and encourage a data-focused approach in this area.

Reference url

Recent Posts

Dutch Health Disruption
     

Dutch Health Disruption: Reimagining Care with Social Entrepreneurship

🔍 Are we ready to rethink our healthcare system for a sustainable future?

Michel van Schaik, Director of Healthcare at Rabobank, argues that the traditional Dutch health model is no longer viable. In his recent article, he advocates for innovative solutions outside the conventional framework, emphasizing community-based initiatives and prevention over treatment to address escalating costs and workforce shortages.

Dive into his vision for a society that prioritizes well-being and citizen collaboration by 2040. Explore the transformative ideas that could redefine our approach to health!

#SyenzaNews #HealthcareInnovation #HealthEconomics

pharmaceutical industry Europe
    

Pharmaceutical Industry Europe: Key Insights and Future Challenges for 2025

💡 How is the pharmaceutical industry in Europe poised to navigate the challenges of 2025?

As the industry faces fierce competition, regulatory hurdles, and evolving market dynamics, this article provides key insights into R&D investments, employment trends, and the urgent need for policy reforms. Discover how Europe can leverage its strengths to maintain its leadership in global life sciences.

Jump into these pivotal developments and strategies by reading the full article!

#SyenzaNews #pharmaceuticals #healthcarepolicy

prior authorization reforms
     

Streamlining Prior Authorization Reforms: Impacts and Insights for HEOR

🚀 Are prior authorizations stalling care delivery in the U.S. healthcare system?

The HHS has launched an ambitious collaboration with major insurers to reform prior authorization processes across Medicare Advantage, Medicaid, and commercial plans. With a goal to standardize submissions by 2027 and significantly reduce requirements by 2026, this initiative promises to accelerate care decisions and enhance transparency.

Dive into the details of these pivotal reforms and discover their potential to streamline healthcare and improve patient outcomes.

#SyenzaNews #HealthcareInnovation #healthcare #healthcarepolicy

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.